There're still spending way too much for my liking. The +$4m on working capital needs way more of an explanation as this is way too high for a company of it's type. Also, $3m of sales vs $2.8m of cash received may debunk the notion of a decent receivables book. I think they need a bloke in the team who understands finances rather than a bunch of spend thrift financially clueless doctors. Personally, this 4c is a huge disappointment. I say cut sales staff massively for a few quarters and see if growth in sales maintains trajectory.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.30 |
Change
-0.300(5.36%) |
Mkt cap ! $82.17M | |||
| Open | High | Low | Value | Volume |
| $5.51 | $5.52 | $5.22 | $220.2K | 40.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 822 | $5.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.40 | 1097 | 2 |
View Market Depth
| Last trade - 15.47pm 10/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |